Selective Anticancer Effects by Oxyclozanide in Triple-Negative Breast Cancer Expressing S100A9-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Selective Anticancer Effects by Oxyclozanide in Triple-Negative Breast Cancer Expressing S100A9

Published:2022-07-31 Issue:1 Volume:1 Page:1-11
ISSN:2951-3359
Container-title:Drug Targets and Therapeutics
language:en
Short-container-title:DTT

Author:

Hwang Hyun Hwan¹,Chang Ki Ho²,Choi Yi Young²,Jung Ii-Du²,Kang In-Cheol³,Choi Youngjin⁴,O Mi Jin¹,Cho Chang-Keun¹^ORCID,Kang Pureum¹^ORCID,Park Hye-Jung¹^ORCID,Jang Choon-Gon¹^ORCID,Lee Seok-Yong¹^ORCID

Affiliation:

1. School of Pharmacy, Sungkyungkwan University, Suwon, Korea

2. Department of RND Center, Ahngook Pharm, Seoul, Korea

3. Department of Biological Science, Hoseo University, Asan, Korea

4. Department of Food Science & Technology, Hoseo University, Asan, Korea

Publisher

Drug Targets and Therapeutics (DTT) - Pharmaceutical Society of Korea

Link

http://pdf.medrang.co.kr/DTT/2022/001/01. DTT 22-003.pdf

Reference39 articles.

1. S100A8 and S100A9 Overexpression Is Associated with Poor Pathological Parameters in Invasive Ductal Carcinoma of the Breast

2. S100A9 expression in invasive ductal carcinoma of the breast

3. Immunohistochemical investigation of S100A9 expression in pulmonary adenocarcinoma: S100A9 expression is associated with tumor differentiation

4. Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists

5. Tumorigenesis and the angiogenic switch

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP